MBI-002

N/A

Report date: 2025/02/07 11:48:34

Base Information

Drug NameMBI-002
Drug Alias NameMBI-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunostimulantsCheckpoint kinase modulators
TargetsCheckpoint kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMycenax Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesMycenax Biotech Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A